Fundraising Fox
/Companies
Sign in

EdiTy Therapeutics

Rehovot, IL · Founded 2020 · 22 employees on LinkedIn · 6 known investors

Find your way into EdiTy Therapeutics

Sign up to see every warm intro you have to EdiTy Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the EdiTy Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Edity develops an AI-powered platform that engineers therapeutic proteins and uses immune cells (such as T-cells and NK cells) as carriers to deliver them to diseased tissues. Its plug-and-play technology is compatible with allogeneic approaches and aimed at creating new modalities for intracellular therapy.

AI & Machine LearningBiotechHealthtech

Founders & leadership

EdiTy Therapeutics was founded in 2020 by Eyal Kolka and Michal Golan-Mashiach.

EK
Eyal KolkaCo-founder, Chairman of the Board
MGMichal Golan-Mashiach
Michal Golan-MashiachFounder & CEOMichal Golan-Mashiach holds a Ph.D. in Systems Biology from the Weizmann Institute and brings over 15 years of experience in genetics, bioinformatics, and computational biology, including prior roles as Chief Scientific Officer at Dr. Gene and clinical consultant for diagnostic and gene-editing companies in Israel.

Investors · 6

Loop VClisted by Loop VC
NFXlisted by NFXSan Francisco · $250K – $5M
Tal Ventureslisted by Tal VenturesTel Aviv

How we know: Tal Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Blumberg CapitalreportedMiami · $500K – $5M

How we know: a partner's Signal profile · Not right? Tell us

O.G. Venture PartnersreportedTel Aviv-Yafo · $5M – $15M

How we know: a partner's Signal profile · Not right? Tell us

Founder mafia

2 people who came through EdiTy Therapeutics went on to found or lead other companies.

Alexandra (Sandra) GlucksmannBoard MemberFounded Sensorium TherapeuticsOmri DroryBoard MemberFounded Renewal Bio

Frequently asked questions

What does EdiTy Therapeutics do?
Edity develops an AI-powered platform that engineers therapeutic proteins and uses immune cells (such as T-cells and NK cells) as carriers to deliver them to diseased tissues. Its plug-and-play technology is compatible with allogeneic approaches and aimed at creating new modalities for intracellular therapy.
Who founded EdiTy Therapeutics?
EdiTy Therapeutics was founded by Eyal Kolka, Michal Golan-Mashiach in 2020.
Who are EdiTy Therapeutics's investors?
EdiTy Therapeutics's investors include Gaingels, Loop VC, NFX, Tal Ventures, Blumberg Capital, O.G. Venture Partners.
Where is EdiTy Therapeutics headquartered?
EdiTy Therapeutics is headquartered in Rehovot, IL.